Publications by authors named "Signes-Costa J"

Background: Chronic obstructive pulmonary disease (COPD), usually caused by long-term tobacco smoking, is independently associated with systemic inflammation. However, little is known about the systemic inflammatory status of patients with early-stage COPD (classified as GOLD 1) and long-term smokers with normal lung function (LF). Here, we characterised the early changes in the associated inflammatory state in patients with GOLD 1 and in long-term smokers with normal LF.

View Article and Find Full Text PDF

The Platelia Aspergillus Antigen immunoassay is the "gold standard" for Aspergillus galactomannan (GLM) measurement in sera and bronchoalveolar lavage (BAL) for the diagnosis of invasive pulmonary aspergillosis (IPA). We evaluated the performance of the Aspergillus GLM antigen Virclia Monotest compared to the Platelia assay. A total of 535 specimens [320 sera, 86 bronchial aspirates (BAs), 70 BAL, and 59 tracheal aspirates (TAs)] from 177 adult patients (72 hematological, 32 Intensive Care Unit, and 73 hospitalized in other wards) were processed for GLM testing upon clinical request.

View Article and Find Full Text PDF

Background: Surgical excision biopsy remains the only reliable option in most cases of indeterminate pulmonary nodules, particularly in cancer survivors for whom surgery provides local control of pulmonary metastasis and the best chance of cure for early-stage lung cancer. Nevertheless, unnecessary surgeries remain a concern and the prognosis of newly diagnosed lung cancer might be influenced by the history of previous malignancy. We aimed to analyze the outcomes of resected indeterminate pulmonary nodules in patients with and without previous malignancy, and the impact of prior cancer history on survival and recurrence in stage I non-small cell lung cancer (NSCLC) patients.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed data from the HOPE-2 registry, examining 2382 patients discharged alive and tracking their mortality and long-term COVID-19 symptoms.
  • * Findings reveal that patients with elevated troponin levels face higher mortality rates and are more likely to experience lasting cardiovascular issues, such as fatigue and dyspnea, after discharge.
View Article and Find Full Text PDF

Introduction: The interaction between smoking and asthma impairs lung function and increases airflow obstruction severity. The identification of smoking patterns in smokers with and without asthma is crucial to provide the best care strategies. The aims of this study are to estimate asthma frequency, describe asthma features, and characterize smoking in smokers attending smoking cessation units.

View Article and Find Full Text PDF
Article Synopsis
  • Noninvasive ventilation (NIV) is essential for preventing intubation in myasthenic crisis, but there is limited research on its long-term use in stable myasthenia gravis (MG) patients.
  • A study analyzed 50 MG patients, finding 20% required long-term home NIV, particularly among those with more severe MG symptoms (grades IIB and IIIB).
  • The research suggests that identifying MG severity can help predict which patients may need NIV, highlighting the prevalence of this intervention in stable individuals with generalized MG and bulbar or respiratory involvement.
View Article and Find Full Text PDF

The SARS-CoV-2 coronavirus is responsible for the COVID-19 pandemic resulting in a global health emergency. Given its rapid spread and high number of infected individuals, a diagnostic tool for a rapid, simple, and cost-effective detection was essential. In this work, we developed a COVID-19 diagnostic test, that incorporates a human internal control, based on the Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP).

View Article and Find Full Text PDF

Background: Concern has risen about the effects of COVID-19 in interstitial lung disease (ILD) patients. The aim of our study was to determine clinical characteristics and prognostic factors of ILD patients admitted for COVID-19.

Methods: Ancillary analysis of an international, multicenter COVID-19 registry (HOPE: Health Outcome Predictive Evaluation) was performed.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with diabetes mellitus (DM) experience a higher long-term mortality rate post-COVID-19 compared to those without DM.
  • Among the studied symptoms, diabetics showed fewer cardiovascular complaints but a higher incidence of psychiatric issues like paranoia, and more respiratory complications as evidenced by abnormal spirometry.
  • Rates of readmission and reinfection after COVID-19 were similar for both diabetic and non-diabetic patients, indicating that the presence of diabetes does not significantly impact these outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates long-term effects of COVID-19, focusing on fibrogenesis biomarkers in patients with pneumonia to predict post-COVID pulmonary issues.
  • Conducted with 135 patients over 12 months, results showed significant radiological and functional improvements, but some patients still exhibited fibrotic changes.
  • Notably, early periostin levels after discharge were associated with increased likelihood of fibrotic changes and lung function impairment at the 12-month mark.
View Article and Find Full Text PDF
Article Synopsis
  • Heart disease significantly worsens outcomes for COVID-19 survivors, leading to higher rates of post-COVID complications and increased mortality.
  • In a study involving over 7,000 patients, those with heart disease were generally older with more health issues compared to those without, showing a 2.63 times higher risk of death.
  • The research highlights that vaccination against COVID-19 offers substantial protection, drastically lowering the risk of mortality for patients with pre-existing heart conditions.
View Article and Find Full Text PDF

Idiopathic pulmonary fibrosis is an interstitial lung disease of unknown etiology with a highly compromised prognosis and a significant mortality rate within a few years of diagnosis. Despite being idiopathic, it has been shown that telomeric shortening could play an important role in its etiopathogenesis. Mutations in telomere-related genes have been identified, but they are not always present despite telomere shortening.

View Article and Find Full Text PDF

Background: The coronavirus disease (COVID-19) pandemic has already affected more than 400 million people, with increasing numbers of survivors. These data indicate that a myriad of people may be affected by pulmonary sequelae of the infection. The aim of this study was to evaluate pulmonary sequelae in patients with bilateral COVID-19 pneumonia according to severity 1 year after hospital discharge.

View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 has significantly strained healthcare systems, necessitating a better understanding of its severe forms to develop effective treatments.
  • Researchers analyzed blood samples from 78 patients to identify biomarkers that could predict the worsening of the disease based on inflammation and admission health metrics.
  • Results indicated strong correlations between the severity of lung edema (measured by RALE score), inflammatory markers, and patient outcomes, suggesting potential therapeutic targets and strategies for managing COVID-19 complications.
View Article and Find Full Text PDF

Background: Effectiveness of mechanical assisted coughing with insufflation-exsufflation (MI-E) in amyotrophic lateral sclerosis (ALS) depends largely on severity of bulbar dysfunction, which can generate different upper-airway responses. The aim of the study was to evaluate the use of graphs generated by MI-E in ALS to detect airway obstruction and set parameters to achieve an effective mechanically assisted coughing.

Methods: This was a prospective study enrolling patients with ALS.

View Article and Find Full Text PDF

In the lungs, fibrosis is a growing clinical problem that results in shortness of breath and can end up in respiratory failure. Even though the main fibrotic disease affecting the lung is idiopathic pulmonary fibrosis (IPF), which affects the interstitial space, there are many fibrotic events that have high and dangerous consequences for the lungs. Asthma, chronic obstructive pulmonary disease (COPD), excessive allergies, clearance of infection or COVID-19, all are frequent diseases that show lung fibrosis.

View Article and Find Full Text PDF

Background COVID-19 is an infectious illness, featured by an increased risk of thromboembolism. However, no standard antithrombotic therapy is currently recommended for patients hospitalized with COVID-19. The aim of this study was to evaluate safety and efficacy of additional therapy with aspirin over prophylactic anticoagulation (PAC) in patients hospitalized with COVID-19 and its impact on survival.

View Article and Find Full Text PDF
Article Synopsis
  • Most COVID-19 research focuses on hospitalized patients, leaving the impact of prior oral anticoagulation (OAC) therapy before admission understudied.
  • Analyzing data from the HOPE COVID-19 Registry, the study compared outcomes between hospitalized patients who had or hadn’t used OAC prior to their admission.
  • Results indicated that patients on prior OAC faced a higher risk of mortality and adverse outcomes than those without OAC, with no significant differences between types of OAC used (VKAs vs. DOACs).
View Article and Find Full Text PDF

Background: High-Flow Nasal Cannula (HFNC) therapy is useful treatment in patients with acute respiratory failure (ARF). The ROX index (ratio of pulse oximetry/fraction of inspired oxygen to respiratory rate) has been evaluated to predict success of HFNC in patients with pneumonia.

Objective: The aim of this study was to determine whether the ROX Index could predict HFNC therapy success in patients with ARF due to SARS-CoV-2 pneumonia.

View Article and Find Full Text PDF

Introduction: Patients with pre-existing respiratory diseases in the setting of COVID-19 may have a greater risk of severe complications and even death.

Methods: A retrospective, multicenter, cohort study with 5847 COVID-19 patients admitted to hospitals. Patients were separated in two groups, with/without previous lung disease.

View Article and Find Full Text PDF